論文 - 黒瀬　光一

副作用バイオマーカーの探索と臨床応用研究の現状について

斎藤嘉朗，中村亮介，黒瀬光一 , 2013年09月

臨床病理レビュー , 特集150号 , 27 - 33

Population differences in major functional polymorphisms of pharmacokinetics/pharmacodynamics-related genes in Eastern Asians and Europeans: implications in the clinical trials for novel drug development.

Kurose K, Sugiyama E, Saito Y. , 2012年09月

Drug Metab Pharmacokinet. , 27 (1) , 9 - 54

Development of a rapid and inexpensive assay for detecting a surrogate genetic polymorphism of HLA-B*58:01: a partially predictive but useful biomarker for allopurinol-related Stevens-Johnson syndrome/toxic epidermal necrolysis in Japanese

Maekawa K, Nishikawa J, Kaniwa N, Sugiyama E, Koizumi T, Kurose K, et al. , 2012年09月

Drug Metab Pharmacokinet. , 27 (4) , 447 - 450

Genome-wide association study of SSRI/SNRI-induced sexual dysfunction in a Japanese cohort with major depression

Kurose K, Hiratsuka K, Ishiwata K, et al. , 2012年09月

Psychiatry Res. , 198 (3) , 424 - 429

Genetic polymorphisms of FCGR2A encoding Fcγ receptor IIa in a Japanese population and functional analysis of the L273P variant

Tada M, Ishii-Watabe A, Maekawa K, Fukushima-Uesaka H, Kurose K,et al. , 2012年09月

Immunogenetics , 64 (12) , 869 - 877

Quality requirements for genomic DNA preparations and storage conditions for a high-density oligonucleotide microarray

Kurose K, Koizumi T, Nishikawa J, Maekawa K, Saito Y. , 2012年09月

Biol Pharm Bull. , 35 (10) , 1846 - 1848

ゲノム情報に基づいた副作用予測.

黒瀬光一，斎藤嘉朗 , 2012年02月

日本臨牀 , 70 (増刊号6) , 18 - 24

Genetic variation and haplotype structures of the glutathione S-transferase genes, GSTA1 and GSTA2 in Japanese colorectal cancer patients.

Maekawa K, Hamaguchi T, Saito Y, Tatewaki N, Kurose K, Kaniwa N, Nakajima TE, Kato K, Yamada Y, Shimada Y, Yoshida T, Kamatani N, Ura T, Saito M, Muro K, Fuse N, Yoshino T, Doi T, Otsu A, Saijo N, Sawada J, Okuda H, Matsumura Y. , 2011年09月

Drug Metab. Pharmacokinet. , 26 (6) , 646 - 658

Functional analysis of genetic variations in the 5'-flanking region of the human MDR1 gene.

Saeki M, Kurose K, Hasegawa R, Tohkin M , 2011年09月

Molecular Genetics and Metabolism , 102(1) , 91 - 98

Genetic polymorphisms and haplotypes of POR, encoding cytochrome P450 oxidoreductase, in a Japanese population

Saito Y, Yamamoto N, Katori N, Maekawa K, Fukushima-Uesaka H, Sugimoto D, Kurose K, Sai K, Kaniwa N, Sawada J, Kunitoh H, Ohe Y, Yoshida T, Matsumura Y, Saijo N, Okuda H, Tamura T. , 2011年09月

Drug Metab. Pharmacokinet. , 26(1) , 107 - 116

Genetic variations of orosomucoid genes associated with serum alpha-1-acid glycoprotein level and the pharmacokinetics of paclitaxel in Japanese cancer patients.

Katori N, Sai K, Saito Y, Fukushima-Uesaka H, Kurose K, Yomota C, Kawanishi T, Nishimaki-Mogami T, Naito M, Sawada J, Kunitoh H, Nokihara H, Sekine I, Ohe Y, Yoshida T, Matsumura Y, Saijo N, Yamamoto N, Okuda H, Tamura T. , 2011年09月

J. Pharm. Sci. , 100(10) , 4546 - 4559

Genetic polymorphisms of FCGRT encoding FcRn in a Japanese population and their functional analysis.

Ishii-Watabe A, Saito Y, Suzuki T, Tada M, Ukaji M, Maekawa K, Kurose K, Kaniwa N, Sawada J, Kawasaki N, Yamaguchi T, Eguchi Nakajima T, Kato K, Yamada Y, Shimada Y, Yoshida T, Ura T, Saito M, Muro K, Doi T, Fuse N, Yoshino T, Ohtsu A, Saijo N, Hamaguchi T, Okuda H, Matsumura Y , 2010年09月

Drug Metab. Pharmacokinet. , 25(6) , 578 - 587

HLA-B*1511 is a risk factor for carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients.

Kaniwa N, Saito Y, Aihara M, Matsunaga K, Tohkin M, Kurose K, Furuya H, Takahashi Y, Muramatsu M, Kinoshita S, Abe M, Ikeda H, Kashiwagi M, Song Y, Ueta M, Sotozono C, Ikezawa Z, Hasegawa R, JSAR research group. , 2010年09月

Epilepsia , 51(12) , 2461 - 2465

Prediction of severe adverse drug reactions from pharmacogenetic biomarkers, drug metabolism and pharmacokinetics.

Tohkin M, Ishiguro A, Kaniwa N, Saito Y, Kurose K, Hasegawa R , 2010年09月

Drug Metab. Pharmacokinet. , 25 (2) , 122 - 133

Genetic polymorphisms of copper- and platinum drug- efflux transporters ATP7A and ATP7B in Japanese cancer patients.

Fukushima-Uesaka H, Saito Y, Maekawa K, Kurose K, Sugiyama E, Katori N, Kaniwa N, Hasegawa R, Hamaguchi T, Eguchi-Nakajima T, Kato K, Yamada Y, Shimada Y, Yoshida T, Yamamoto N, Nokihara H, Kunitoh H, Ohe Y, Tamura T, Ura T, Saito M, Muro K, Doi T, Fuse N, Yoshino T, Ohtsu A, Saijo N, Matsumura Y, Okuda H, Sawada J. , 2009年09月

Drug Metab. Pharmacokinet. , 24(6) , 565 - 574

Genetic variations and haplotype structures of the glutathione S-transferase genes, GSTT1 and GSTM1, in a Japanese patient population.

Tatewaki N, Maekawa K, Katori N, Kurose K, Kaniwa N, Yamamoto N, Kunitoh H, Ohe Y, Nokihara H, Sekine I, Tamura T, Yoshida T, Saijo N, Saito Y, Sawada J. , 2009年09月

Drug Metab. Pharmacokinet. , 24(1) , 118 - 126

Genetic variations and haplotypes of ABCC2 encoding MRP2 in a Japanese population

Sai K, Saito Y, Itoda M, Fukushima-Uesaka H, Nishimaki-Mogami T, Ozawa S, Maekawa K, Kurose K, et al. , 2008年09月

Drug Metabolism and Pharmacokinetics , 23(2) , 139 - 147

Importance of UDP-glucuronosyltransferase 1A1 *6 for irinotecan toxicities in Japanese cancer patients.

Sai K, Saito Y, Sakamoto H, Shirao K, Kurose K, et al. , 2008年09月

Cancer Lett. , 261(2) , 165 - 171

Thyroid hormone receptor mediates human MDR1 gene expression — identification of the response region essential for gene expression

Kurose K, Saeki M, Tohkin M, Hasegawa R , 2008年09月

Archives of Biochemistry and Biophysics , 474(1) , 82 - 90

Impact of CYP3A4 haplotypes on irinotecan pharmacokinetics in Japanese cancer patients

Sai K, Saito Y, Fukushima-Uesaka H, Kurose K, et al. , 2008年09月

Cancer Chemother. Pharmacol. , 62(3) , 529 - 537